Table 4.

Investigator's assessment of haemostatic efficacy of VONCENTO per bleeding event in arm 2 (on-demand) (efficacy population)

		NSB events, N (%)
Bleeding type	NSB eventsa, N	Excellent	Good	Moderate	None
All NSB events	407	374 (92.1)	25 (6.2)	7 (1.7)	0
Spontaneous	403	371 (92.1)	25 (6.2)	7 (1.7)	0
Trauma	3	3 (100.0)	0	0	0
Postsurgery	1	1 (100.0)	0	0	0
Majorb	125	117 (93.6)	2 (1.6)	6 (4.8)	0
Minor	281	257 (91.5)	23 (8.2)	1 (0.3)	0
Jointc	101	99 (98.0)	2 (2.0)	0	0
Mucosalb,c	290	260 (89.7)	23 (7.9)	7 (2.4)	0
Muscle	17	17 (100.0)	0	0	0

N, number of events; NSB, nonsurgical bleeding.

^aNSB events treated with VONCENTO and with a haemostatic efficacy assessment.

^bIncludes seven major mucosal events.

^cTwo bleeding events of one study participant were each counted in both body location categories ‘joint’ and ‘mucosal’.